코로나19임상시험포털

ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.

전체 2310건의 자료가 검색되었습니다.

코로나19(COVID19) 임상시험 현황
No.	Status	Study Title	Conditions	Interventions	Phase	Sponsor/Collaborators	Funder Type	Number Enrolled	Sex	Age	Locations
2128	Terminated	A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)	Coronavirus	Drug: PTC299 Other: SOC Drug: Placebo	Phase 3	PTC Therapeutics	INDUSTRY	189	All	18 Years	University of California, Irvine, Orange, California, United States Augusta University, Augusta, Georgia, United States Johns Hopkins Hospital, Baltimore, Maryland, United States University of Massachusetts Memorial Health Care, Worcester, Massachusetts, United States University Hospitals Cleveland, Cleveland, Ohio, United States Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States Westmead Hospital, Westmead, New South Wales, Australia Monash Medical Centre, Clayton, Victoria, Australia Sunshine Hospital, St. Albans, Victoria, Australia St. Pierre University Hospital, Brussels, Belgium Clinique Saint Pierre, Ottignies, Belgium Hospital Vera Cruz, Belo Horizonte, MG, Brazil Hospital Moinhos de Vento, Porto Alegre, RS, Brazil Centro Hospitalar Unimed (CHU) - Joinville, Joinville, SC, Brazil Hospital Guilherme Alvaro, Santos, SP, Brazil Hospital Santa Casa de Misecordia de Sorocoba, Sorocaba, SP, Brazil Hospital Alemao Oswaldo Cruz, Sao Paulo, SP, Brazil Escola Paulista de Medicina (UNIFESP), Sao Paulo, SP, Brazil Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, Sao Paulo, SP, Brazil Fundacion Santa Fe de Bogota, Bogota, Colombia Centro Cardiovascular Somer Incare, Rionegro, Colombia Hopital Pitie-Salpetriere, Paris, France Centro Hospitalario MAC, Irapuato, Guanajuato, Mexico Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico Integra RGH Centro de Investigacion/ Hospital MAC Puebla, Puebla, Mexico SOMECO - Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico Central Clinic Hospital of the MSWiA in Warsaw, Warsaw, Poland Centro Hospitalar Universitario de Lisboa Norte (CHULN), E.P.E - Hospital de Santa Maria, Lisboa, Portugal Centro Hospitalar de Entre o Douro e Vouga, EPE (CHEDV), Santa Maria da Feira, Portugal Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (CHVNG/E), Vila Nova de Gaia, Portugal Worthwhile Clinical Trials, Benoni, South Africa TREAD Research, Cape Town, South Africa Tiervlei Trial Centre, Cape Town, South Africa Ahmed Al-Kadi Private Hospital, Durban, South Africa Global Clinical Trials, Pretoria, South Africa Hospital Del Mar, Barcelona, Spain Hospital Universitario de Bellvitge, Barcelona, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain Hospital 12 de Octubre, Madrid, Spain Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Spain
2127	Withdrawn	A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19	COVID-19	Drug: SCTA01 and SCTA01C Drug: Placebo	Phase 2	Sinocelltech Ltd.	INDUSTRY	0	All	18 Years
2126	Completed	A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults	Covid19 Vaccine	Biological: MVC-COV1901 Biological: AZD1222	Phase 3	Medigen Vaccine Biologics Corp.	INDUSTRY	1030	All	18 Years	Hospital Fundacion Tesai, Ciudad del Este, Paraguay Hospital de Clinicas - Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, San Lorenzo, Paraguay
2125	Completed	A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents	Covid19 Vaccine	Biological: MVC-COV1901(S protein with adjuvant) Biological: MVC-COV1901(Saline)	Phase 2	Medigen Vaccine Biologics Corp.	INDUSTRY	399	All	12 Years ~ 18 Years	Mackay Memorial Hospital Hsinchu, Hsinchu, Taiwan Chang-Guang Memorial Hospital Lin-Kou, Taipei, Taiwan MacKay Memorial Hospital, Taipei, Taiwan National Taiwan University Hospital-HsinChu, Taipei, Taiwan National Taiwan University Hosptial, Taipei, Taiwan
2124	Completed	A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult	Covid19 Vaccine	Biological: MVC-COV1901(S protein with adjuvant) Biological: MVC-COV1901(Saline)	Phase 2	Medigen Vaccine Biologics Corp.	INDUSTRY	3854	All	20 Years	Changhua Christian Hospital, Changhua, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan China Medical University Hospital, Taichung, Taiwan National Cheng Kung University Hospital, Tainan, Taiwan National Taiwan University Hospital, Taipei, Taiwan Taipei Medical University Hospital, Taipei, Taiwan Taipei Municipal Wan Fang Hospital, Taipei, Taiwan Taipei Veteran General Hospital, Taipei, Taiwan Tri-Service General Hospital, Taipei, Taiwan Chang-Guang Memorial Hospital Lin-Kou, Taoyuan, Taiwan Tao-Yuan General Hospital, Taoyuan, Taiwan National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
2123	Completed	A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults	Covid19 Vaccine	Biological: MVC-COV1901 (High-Dose) Biological: MVC-COV1901(Mid-Dose)	Phase 2	Medigen Vaccine Biologics Corp.	INDUSTRY	420	All	65 Years	Hualien Tzu Chi Hospital, Hualien City, Taiwan Shuang H Hospital, New Taipei City, Taiwan National Taiwan University Hospital, Taipei, Taiwan Chang Gung Medical Hospital Linkou, Taoyuan, Taiwan
2122	Terminated	A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients	COVID-19	Drug: OP-101 Drug: Placebo	Phase 2	Ashvattha Therapeutics, Inc.	INDUSTRY	28	All	18 Years	Research Site, Loma Linda, California, United States Research site, Fort Lauderdale, Florida, United States Research site, Jacksonville, Florida, United States Research Site, Atlanta, Georgia, United States Research site, Baltimore, Maryland, United States Research Site, Sioux Falls, South Dakota, United States Research Site, Amarillo, Texas, United States Research Site, Houston, Texas, United States